enzyme kinetics and inhibition

ENZYME KINETICS AND INHIBITION

ENZYME DEFINITION AND PROPERTIES

  • Enzymes: Defined as 'biocatalysts' synthesized by living cells.

  • Catalysts: Chemical agents that change the rate of a reaction without themselves being consumed.

  • Composition: All enzymes are proteins except for ribozymes, which are RNA that act as enzymes.

  • Characteristics: Colloidal, thermolabile in nature, and specific in their action. Found in all body tissues and fluids - can be extracellular, intracellular, or membrane-bound.

ENZYME MECHANISM OF ACTION AND CATALYTIC ACTIVITY

  • Activation Energy: Enzymes lower the activation energy of reactions, facilitating the transition state.

  • Holoenzyme vs. Apoenzyme:

    • Apoenzyme: Enzyme without its nonprotein component, inactive.

    • Holoenzyme: Catalytically active enzyme with its nonprotein component.

IUBMB ENZYME CLASSIFICATION

  • Enzyme Commission (EC) Classification:

    • A unique four-digit number preceded by "EC" that classifies enzymes.

    • First digit: Class, Second digit: Subclass, Third digit: Sub-subclass, Fourth digit: Serial number.

  • Enzyme Classes (IUBMB):

    1. Oxidoreductases

    2. Transferases

    3. Hydrolases

    4. Lyases

    5. Isomerases

    6. Ligases

    7. Translocases

  • Mnemonic to remember classes: OTHLIL.

ACTIVE SITE AND CATALYSIS

  • Active Site: Area on the enzyme formed by folding of the protein, where substrate binding occurs.

    • Contains amino acid side chains and acts as a flexible template to bind substrate and initiate conversion to the transition state.

  • Characteristics:

    • Responsible for substrate specificity.

    • Contains substrate binding and catalytic sites.

    • Coenzymes or cofactors may bind to these sites.

    • Weak non-covalent bonds (hydrogen bonds) exist between enzyme and substrate.

  • Enzyme-Substrate Interaction:

    • The substrate binds the active site forming the enzyme-substrate (ES) complex.

    • ESTransition:

    • E+S<br>ightleftharpoons[ES]<br>ightleftharpoons[EP]<br>ightleftharpoonsE+PE + S <br>ightleftharpoons [ES] <br>ightleftharpoons [EP] <br>ightleftharpoons E + P

FACTORS AFFECTING ENZYME ACTIVITY

  1. Enzyme Concentration [E]:

    • Reaction velocity (v) increases linearly with enzyme concentration.

    • Doubling enzyme concentration doubles the number of binding sites, thus doubling the reaction rate.

  2. Temperature:

    • Reaction velocity increases with temperature up to an optimum, after which it declines (bell-shaped curve).

    • Optimum Temperature: Generally 37°C, varies for specific enzymes (e.g., urease: 55°C).

    • Q10 Temperature Coefficient: Velocity doubles for every 10°C increase in temperature until optimum.

  3. pH:

    • Reaction velocity increases with increased pH until a maximum, has a bell-shaped curve.

    • Optimum pH: Most enzymes work between pH 6 to 8; specific enzymes have their own ranges (e.g., pepsin: pH 1–2).

  4. Substrate Concentration [S]:

    • Graph of reaction velocity vs. substrate concentration shows three phases:

      • Linear (first order with respect to [S])

      • Curved (mixed-order)

      • Plateau (zero-order when all enzyme active sites are saturated).

  5. Activator Effects:

    • Inorganic ions enhance enzyme activity:

      • Anionic activators (e.g., chloride ions activate salivary amylase).

      • Cationic activators (e.g., calcium ions activate lipases).

  6. Inhibitors:

    • Product accumulation can slow down reactions; quick removal and feedback inhibition are necessary to maintain reaction rates. Example: HMG CoA reductase feedback inhibition by cholesterol.

ENZYME ACTION MECHANISMS

  1. Lock and Key Model (Emil Fischer, 1890):

    • The active site of the unbound enzyme is complementary to the substrate shape.

  2. Induced Fit Model (Daniel Koshland, 1958):

    • The enzyme changes shape upon substrate binding, making the active site complementary to the substrate. This model allows enhanced catalysis by creating stress on the substrate.

SUBSTRATE STRAIN THEORY

  • Substrate Strain: Enzyme-substrate interactions can distort the substrate's bonds, leading to the transition state. This mechanism drives the reaction forward.

  • Transition State Complex: Represents the unstable intermediate before product formation. Weak interactions are optimized in this state.

KINETICS OF ENZYME REACTIONS

  • Kinetics: Derived from Greek "kinetos," referring to movement; the study of reaction rates under varying conditions.

  • Michaelis-Menten Model:

    • extVo=racV<em>extmax[S]K</em>m+[S]ext{Vo} = rac{V<em>{ ext{max}}[S]}{K</em>m + [S]}

    • Where:

    • Vo = Initial velocity,

    • Vmax = Maximal velocity,

    • Km = Michaelis constant.

  • Significance of Km:

    • Independent of enzyme concentration; a constant characteristic of enzyme affinity for its substrate.

    • Low Km indicates high affinity; high Km indicates low affinity.

ENZYME INHIBITION

  • Types of Enzyme Inhibition:

    • Competitive Inhibition:

    • Competitors for the active site resemble substrates, reversible by excess substrate.

    • Effects on kinetics:

      • Increased Km.

      • Vmax unchanged.

    • Example: Malonate inhibits succinate dehydrogenase.

    • Non-Competitive Inhibition:

    • Inhibitor binds at a site different from the active site, not relieved by substrate concentration.

    • Effects on kinetics:

      • Km unchanged.

      • Decreased Vmax.

    • Irreversible Inhibition:

    • Inhibitor binds covalently to the active site; often toxic.

    • Example: Cyanide inhibits cytochrome oxidase.

BIOMEDICAL IMPORTANCE OF INHIBITION

  • Sulphonamides: Competitive inhibitors of dihydropteroate synthetase, blocking folic acid synthesis in bacteria.

  • Methotrexate: Inhibits folate reductase in cancer therapy by mimicking folic acid.

  • Statins (e.g., Lovastatin): Compete with HMG CoA for the active site on HMG CoA reductase, decreasing cholesterol synthesis in the liver.

ASSESSMENT AND CASE SCENARIOS

  • Enzymatic classifications, mechanisms of action, and kinetic properties are critical assessment points for understanding enzymatic functions.

  • Case scenarios involve clinical presentations related to enzyme activity and diagnosis, emphasizing the practical implications of enzyme kinetics in health and disease management.